Related Experiment Video
Updated: May 31, 2026

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
Positron emission tomography for the evaluation and treatment of cardiomyopathy
Palak Shah1, Brian G Choi, Ramesh Mazhari
1Division of Cardiology, George Washington University, Washington, DC, USA. palak@gwu.edu
Insights
Positron emission tomography (PET) aids in diagnosing various cardiomyopathies and evaluating congestive heart failure treatments. Molecular imaging, including PET/CT, is crucial for monitoring cardiovascular stem cell therapy effectiveness.
Area of Science:
- Cardiology
- Nuclear Medicine
- Regenerative Medicine
Background:
- Congestive heart failure (CHF) causes significant global morbidity and mortality, with coronary artery disease being the most common cause of cardiomyopathy.
- Positron emission tomography (PET) is increasingly utilized in evaluating patients with cardiomyopathy.
- Assessing the efficacy of current CHF treatments is vital due to rising healthcare costs.
Purpose of the Study:
- To review the established and expanding role of PET in evaluating cardiomyopathies.
- To highlight the application of PET in specific conditions like hypertrophic cardiomyopathy, cardiac sarcoidosis, and diabetic cardiomyopathy.
- To discuss the importance of molecular imaging, particularly PET/CT, in monitoring cardiovascular stem cell therapy.
Main Methods:
- Review of existing literature on PET applications in cardiomyopathy.
- Discussion of PET/CT's role in assessing stem cell therapy efficacy.
- Exploration of mechanisms underlying stem cell benefits in cardiovascular disease.
Main Results:
- PET is a valuable tool for diagnosing and managing various cardiomyopathies.
- PET/CT imaging is essential for noninvasively monitoring stem cell therapy in cardiovascular disease.
- Understanding stem cell mechanisms is key to advancing cardiovascular regenerative medicine.
Conclusions:
- PET imaging plays a critical role in the management of patients with diverse cardiomyopathies.
- Molecular imaging techniques like PET/CT are indispensable for tracking the progress and efficacy of cardiovascular stem cell therapies.
- Continued research in stem cell therapy and its monitoring via advanced imaging holds promise for future cardiovascular disease treatment.
Abstract:
Congestive heart failure accounts for tremendous morbidity and mortality worldwide. There are numerous causes of cardiomyopathy, the most common of which is coronary artery disease. Positron emission tomography (PET) has an established and expanding role in the evaluation of patients with cardiomyopathy. The specific application of PET to hypertrophic cardiomyopathy, cardiac sarcoidosis, and diabetic cardiomyopathy has been studied extensively and promises to be a useful tool for managing these patients. Furthermore, evaluating the efficacy of standard treatments for congestive heart failure is important as health care costs continue to rise. Recently, there have been significant developments in the field of cardiovascular stem cell research. Familiarity with the mechanisms by which stem cells benefit patients with cardiovascular disease is the key to understanding these advances. Molecular imaging techniques including PET/CT imaging play an important role in monitoring stem cell therapy in both animals and humans. These noninvasive imaging techniques will be highlighted in this paper.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Cardiomyopathy II: Dilated Cardiomyopathy
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies for Cardiovascular System V: CT
Cardiomyopathy IV: Restrictive Cardiomyopathy

